Delivery Order SPE2DB20D3103-SPE2DB25FP4H7
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Afinitor 10 mg tablets. The contract has a ceiling value of $20,805.32 and a period of performance ending on September 20, 2024. The contract is a firm-fixed-price type, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,333.53, is for the delivery of Afinitor Disperz 5 mg Tablets and has an ultimate completion date of April 24, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,828.76 firm fixed-price delivery order is for the supply of AFINITOR DISPERZ 2 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,249.49, is for the delivery of Afinitor Disperz 5 mg tablets. The contract is not set aside and is a firm fixed-price delivery order. It has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Afinitor 10 mg tablets, a specialty pharmaceutical product. The contract has a ceiling value of $41,610.64 and an ultimate completion date of October 21, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various government agencies,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $23,831.92 for the pharmaceutical product AFINITOR DISPERZ 3 MG TABLET 28S. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,721.64 firm fixed-price delivery order is for the supply of AFINITOR 10 MG TABLET UD 28S, a pharmaceutical product, with a completion date of March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Afinitor Disperz 2 mg tablets. The contract was awarded on August 5, 2024, with a ceiling value of $20,106.78 and an ultimate completion date of August 26, 2024. This appears to be a firm fixed-price contract for the delivery of pharmaceutical products. The contract is not set aside for any specific business category. Amerisourcebergen is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mg Everolimus tablets, with a ceiling value of $13,739.02 and a period of performance through June 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Everolimus 10 mg tablets. The award has a ceiling value of $6,791.30 and a completion date of June 11, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4H7Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Afinitor 5 mg tablets and has a ceiling value of $12,352.52. It is a firm fixed price delivery order contract with a performance period ending on July 29, 2025. The contract is not set aside and was awarded on July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 7/8/25 |